Diane E. Sullivan - 27 Jul 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Diane E. Sullivan
Issuer symbol
LXRX
Transactions as of
27 Jul 2023
Net transactions value
$0
Form type
4
Filing time
31 Jul 2023, 08:14:56 UTC
Previous filing
21 Jul 2023
Next filing
19 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +96,515 $0.000000 96,515 27 Jul 2023 Common Stock 96,515 $1.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.